首頁 > 市場調查報告書 > 醫療設備

導管心血管設備

全球經導管心臟瓣膜市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

市場調查報告書

商品編碼

1421065

全球經導管心臟瓣膜市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Transcatheter Heart Valve Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 131 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球經導管心臟瓣膜市場需求預計將從 2023 年的 61.2 億美元增至 2032 年的近 237.9 億美元，2024-2032 年研究期間CAGR為 16.29%。

經導管心臟瓣膜（THV）是一種用於經導管主動脈瓣置換術（TAVR）或經導管主動脈瓣植入術（TAVI）的醫療器材。與傳統的心臟直視手術相比，這是一種侵入性較小的治療主動脈瓣狹窄的替代方案，主動脈瓣狹窄是指主動脈瓣變窄，限制心臟血流的疾病。

市場動態

經導管心臟瓣膜（THV）市場受到多種因素的推動，包括全球人口老化，與年齡相關的心臟瓣膜疾病變得越來越普遍。微創手術的吸引力是一個重要的促進因素，經導管主動脈瓣置換術 (TAVR) 提供了心臟直視手術的更好替代方案。不斷的技術進步提高了經導管心臟瓣膜的功效，改進的設計和材料有助於更好的結果。人們越來越認知到這些手術的好處，加上心血管疾病發生率的上升，推動了市場的成長。有利的報銷政策、醫療實體之間的合作以及旨在加強醫療基礎設施的政府舉措也發揮著關鍵作用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球經導管心臟瓣膜市場的各個細分市場進行了包容性評估。經導管心臟瓣膜產業的成長和趨勢為本研究提供了整體方法。

市場區隔

經導管心臟瓣膜市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按應用

經導管主動脈瓣
經導管肺動脈瓣
經導管二尖瓣

依技術

球囊擴張經導管瓣膜
自膨脹式經導管瓣膜

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲經導管心臟瓣膜市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。經導管心臟瓣膜市場的主要參與者包括波士頓科學公司、Bracco Group、Braile Biomedica、Direct Flow Medical、Edwards Lifesciences、JenaValve、St. Jude Medical、Symetis、ValveXchange Inc。本節包括競爭格局的整體視圖其中包括各各模式種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：經導管心臟瓣膜公司的競爭格局

經導管心臟瓣膜市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Boston Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Bracco Group

公司簡介
公司收入
產品
最近的發展

Braile Biomedica

公司簡介
公司收入
產品
最近的發展

Direct Flow Medical

公司簡介
公司收入
產品
最近的發展

Edwards Lifesciences

公司簡介
公司收入
產品
最近的發展

JenaValve

公司簡介
公司收入
產品
最近的發展

St. Jude Medical

公司簡介
公司收入
產品
最近的發展

Symetis

公司簡介
公司收入
產品
最近的發展

ValveXchange Inc.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113300

The global demand for Transcatheter Heart Valve Market is presumed to reach the market size of nearly USD 23.79 BN by 2032 from USD 6.12 BN in 2023 with a CAGR of 16.29% under the study period 2024 - 2032.

Transcatheter heart valve (THV) is a medical device used in transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI). It's a less invasive alternative to traditional open-heart surgery for treating aortic valve stenosis, a condition where the aortic valve becomes narrowed, restricting blood flow from the heart.

MARKET DYNAMICS

The transcatheter heart valve (THV) market is propelled by various factors, including the aging global population, where age-related heart valve diseases are becoming more prevalent. The appeal of less invasive procedures is a significant driver, with Transcatheter Aortic Valve Replacement (TAVR) offering a preferable alternative to open-heart surgery. Continuous technological advancements enhance the efficacy of transcatheter heart valves, with improved designs and materials contributing to better outcomes. Increasing awareness about the benefits of these procedures, coupled with rising cardiovascular disease incidences, fuels the market growth. Favorable reimbursement policies, collaborations between medical entities, and government initiatives aimed at enhancing healthcare infrastructure also play pivotal roles.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of transcatheter heart valve. The growth and trends of transcatheter heart valve industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the transcatheter heart valve market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve

By Technology

Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Transcatheter Heart Valve market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transcatheter Heart Valve market include Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis, ValveXchange Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . TRANSCATHETER HEART VALVE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY APPLICATION

5.1 Overview by Application
5.2 Historical and Forecast Data
5.3 Analysis by Application
5.4 Transcatheter Aortic Valve Historic and Forecast Sales by Regions
5.5 Transcatheter Pulmonary Valve Historic and Forecast Sales by Regions
5.6 Transcatheter Mitral Valve Historic and Forecast Sales by Regions

6 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Balloon Expanded Transcatheter Valve Historic and Forecast Sales by Regions
6.5 Self-Expanded Transcatheter Valve Historic and Forecast Sales by Regions

7 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE TRANSCATHETER HEART VALVE COMPANIES

8.1. Transcatheter Heart Valve Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF TRANSCATHETER HEART VALVE INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Boston Scientific Corporation
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Bracco Group
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Braile Biomedica
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Direct Flow Medical
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Edwards Lifesciences
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. JenaValve
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. St. Jude Medical
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Symetis
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. ValveXchange Inc.
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments